Follow live coverage as Norwich City face Stoke City in the Championship today. An increasingly competitive second tier in ...

The deal, which features up to $385 million in milestones, gives Biogen exclusive rights to commercialize Stoke’s ...

A dad was diagnosed with four of the deadliest brain tumours after feeling 'tingles' in his left arm for a month - and died ...

Stoke Therapeutics Inc. and Biogen Inc. said Tuesday they are entering a collaboration to develop and commercialize a ...

Norwich comfortably saw off Stoke 4-2 at Carrow Road to record their first win in four matches and reignite their bid to ...

The school leaders taking unprecedented action to ensure a safe learning environment with amenities in good working order ...

From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...

In exchange for $165 million, Biogen now has access to zorevunersen, a potential first-of-its-kind treatment for Dravet ...

Discover Stoke Therapeutics' innovative RNA-based treatments like zorevunersen for Dravet syndrome, with a promising pipeline ...

Norwich City will look to keep their play-off hopes alive when they welcome Stoke City to Carrow Road on Saturday afternoon ...

Stoke Therapeutics Inc. and Biogen Inc. said Tuesday they are entering a collaboration to develop and commercialize a treatment for Dravet syndrome, a severe form of epilepsy that starts in childhood.